Clinical Trial Update: Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial [Phase 3]

View source ↗

Summary

Phase 3 TROICA trial evaluating tenecteplase (Metalyse) for thrombolysis in cardiac arrest was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest

Drugs mentioned

• Metalyse (tenecteplase)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Heart Arrest | Phase 3 | Status: TERMINATED